Source:http://linkedlifedata.com/resource/pubmed/id/16024606
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2005-7-18
|
pubmed:abstractText |
The BRAF V600E mutation has been associated with microsatellite instability and the CpG island methylator phenotype (CIMP) in colon cancer. We evaluated a large population-based sample of individuals with colon cancer to determine its relationship to survival and other clinicopathologic variables. The V600E BRAF mutation was seen in 5% (40 of 803) of microsatellite-stable tumors and 51.8% (43 of 83) of microsatellite-unstable tumors. In microsatellite-stable tumors, this mutation was related to poor survival, CIMP high, advanced American Joint Committee on Cancer (AJCC) stage, and family history of colorectal cancer [odds ratio, 4.23; 95% confidence interval (95% CI), 1.65-10.84]. The poor survival was observed in a univariate analysis of 5-year survival (16.7% versus 60.0%; P < 0.01); in an analysis adjusted for age, stage, and tumor site [hazard rate ratio (HRR), 2.97; 95% CI, 2.05-4.32]; in stage-specific, age-adjusted analyses for AJCC stages 2 to 4 (HRR, 4.88, 3.60, and 2.04, respectively); and in Kaplan-Meier survival estimates for AJCC stages 2 to 4 (P < 0.01 for all three stages). Microsatellite-unstable tumors were associated with an excellent 5-year survival whether the V600E mutation was present or absent (76.2% and 75.0%, respectively). We conclude that the BRAF V600E mutation in microsatellite-stable colon cancer is associated with a significantly poorer survival in stages 2 to 4 colon cancer but has no effect on the excellent prognosis of microsatellite-unstable tumors.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA48998,
http://linkedlifedata.com/resource/pubmed/grant/CA61757,
http://linkedlifedata.com/resource/pubmed/grant/N01-PC-67000,
http://linkedlifedata.com/resource/pubmed/grant/R01 CA048998-11,
http://linkedlifedata.com/resource/pubmed/grant/R01 CA061757-10
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6063-9
|
pubmed:dateRevised |
2010-8-9
|
pubmed:meshHeading |
pubmed-meshheading:16024606-Aged,
pubmed-meshheading:16024606-Colonic Neoplasms,
pubmed-meshheading:16024606-CpG Islands,
pubmed-meshheading:16024606-Female,
pubmed-meshheading:16024606-Humans,
pubmed-meshheading:16024606-Male,
pubmed-meshheading:16024606-Microsatellite Repeats,
pubmed-meshheading:16024606-Middle Aged,
pubmed-meshheading:16024606-Mutation,
pubmed-meshheading:16024606-Prognosis,
pubmed-meshheading:16024606-Proto-Oncogene Proteins B-raf,
pubmed-meshheading:16024606-Survival Rate
|
pubmed:year |
2005
|
pubmed:articleTitle |
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.
|
pubmed:affiliation |
Department of Pathology, University of Utah Health Sciences Center, Salt Lake City 84132, USA. wade.samowitz@hsc.utah.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|